Digital program to help melanoma survivors do regular skin self-checks
A digital intervention to improve skin self-examination among melanoma survivors
An app-based program to help melanoma survivors learn and stick with regular, thorough skin self-exams.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11308666 on NIH RePORTER |
What this research studies
You would use an improved version of the mySmartSkin digital program that teaches and supports skin self-exams. The team will work with survivors, clinicians, and clinics to refine the app using interviews and usability testing. Then they will run a larger Type 1 hybrid trial that compares the enhanced program to usual care while also studying how the program could be rolled out in real clinics. The study focuses on both whether the program helps people do thorough self-exams and what makes it easy or hard to use widely.
Who could benefit from this research
Good fit: Ideal participants are melanoma survivors who are past initial treatment and are willing and able to use a smartphone or web program to perform regular skin self-exams.
Not a fit: People without a history of melanoma, those who cannot or will not use digital tools, or those who require only clinician-performed surveillance may not benefit from this program.
Why it matters
Potential benefit: If successful, the program could help melanoma survivors find recurrences or new melanomas earlier by increasing regular, thorough skin self-exams and make that support available to more people.
How similar studies have performed: A prior randomized trial of mySmartSkin in New Jersey showed promising improvements in thorough skin self-exams, and this project builds on that earlier work.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Manne, Sharon L — Rutgers Biomedical and Health Sciences
- Study coordinator: Manne, Sharon L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.